申请人:SMITHKLINE BEECHAM CORP
公开号:WO2005077926A2
公开(公告)日:2005-08-25
A compound of formula (I) and pharmaceutically acceptable salts and solvates and hydrolysable esters thereof, where X, X1, X2, X3, X4 and R, R2, R3, R4 are defined as in claim 1. These compounds are activators of the hPPAR receptors and are useful for the treatment of cardiovascular disease.